Literature DB >> 27001523

Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphoma.

K Shimada1,2, S Shimada3, K Sugimoto2,4, M Nakatochi5, M Suguro6, A Hirakawa5, T D Hocking7, I Takeuchi8, T Tokunaga2,9, Y Takagi2, A Sakamoto2, T Aoki2, T Naoe2,9, S Nakamura3, F Hayakawa2, M Seto6,10, A Tomita2, H Kiyoi2.   

Abstract

Intravascular large B-cell lymphoma (IVLBCL) is a distinct disease entity with the peculiar characteristic that tumor cells proliferate within vessels. Despite recent advances in understanding the disease from clinical aspects, the underlying pathogenesis remains unknown. Here we demonstrate analyses of IVLBCL biology using four xenograft mouse models established from primary IVLBCL samples. In all four models, the main characteristic of IVLBCL tumor cell proliferation within vessels was retained. Time-lapse engraftment analyses revealed that the tumor cells initially engrafted and proliferated in the sinusoids and vessels in the liver and then engrafted and proliferated in multiple organs. Intriguingly, serial passage of tumor cells from the adrenal gland of a transplanted mouse developed from primary patient bone marrow cells into a second mouse showed that the tumor cells mainly distributed into the adrenal gland in the second mouse, implying the existence of clonal selection and/or evolution at engraftment of a specific organ. Gene expression profiling analyses demonstrated that the gene set associated with cell migration was enriched for normal peripheral blood B cells, indicating that inhibition of cell migration might be involved in IVLBCL pathogenesis. In conclusion, the mouse xenograft models described here are essential tools for uncovering IVLBCL biology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27001523     DOI: 10.1038/leu.2016.67

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  30 in total

1.  An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome.

Authors:  T Murase; S Nakamura; K Kawauchi; H Matsuzaki; C Sakai; T Inaba; K Nasu; K Tashiro; T Suchi; H Saito
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

2.  Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy.

Authors:  Akihiro Tomita; Junji Hiraga; Hitoshi Kiyoi; Manabu Ninomiya; Takumi Sugimoto; Masafumi Ito; Tomohiro Kinoshita; Tomoki Naoe
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

3.  Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.

Authors:  Maurilio Ponzoni; Andrés J M Ferreri; Elías Campo; Fabio Facchetti; Luca Mazzucchelli; Tadashi Yoshino; Takuhei Murase; Stefano A Pileri; Claudio Doglioni; Emanuele Zucca; Franco Cavalli; Shigeo Nakamura
Journal:  J Clin Oncol       Date:  2007-06-18       Impact factor: 44.544

4.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice.

Authors:  M Ninomiya; A Abe; A Katsumi; J Xu; M Ito; F Arai; T Suda; M Ito; H Kiyoi; T Kinoshita; T Naoe
Journal:  Leukemia       Date:  2006-10-12       Impact factor: 11.528

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma.

Authors:  Kosei Matsue; Noboru Asada; Jun Odawara; Takayoshi Aoki; Shun-ichi Kimura; Kan-ichi Iwama; Hideaki Fujiwara; Masayuki Yamakura; Masami Takeuchi
Journal:  Ann Hematol       Date:  2010-10-19       Impact factor: 3.673

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

10.  Use of random skin biopsy for diagnosis of intravascular large B-cell lymphoma.

Authors:  Noboru Asada; Jun Odawara; Shun-ichi Kimura; Takatoshi Aoki; Masayuki Yamakura; Masami Takeuchi; Reiko Seki; Atsushi Tanaka; Kosei Matsue
Journal:  Mayo Clin Proc       Date:  2007-12       Impact factor: 7.616

View more
  6 in total

Review 1.  Development and Significance of Mouse Models in Lymphoma Research.

Authors:  Jordan N Noble; Anjali Mishra
Journal:  Curr Hematol Malig Rep       Date:  2019-04       Impact factor: 3.952

Review 2.  Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.

Authors:  Christopher G England; Lixin Rui; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-14       Impact factor: 9.236

3.  Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma.

Authors:  Kazuyuki Shimada; Kenichi Yoshida; Yasuhiro Suzuki; Chisako Iriyama; Yoshikage Inoue; Masashi Sanada; Keisuke Kataoka; Masaaki Yuge; Yusuke Takagi; Shigeru Kusumoto; Yasufumi Masaki; Takahiko Ito; Yuichiro Inagaki; Akinao Okamoto; Yachiyo Kuwatsuka; Masahiro Nakatochi; Satoko Shimada; Hiroaki Miyoshi; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Yusuke Shiozawa; Yasuhito Nannya; Asako Okabe; Kei Kohno; Yoshiko Atsuta; Koichi Ohshima; Shigeo Nakamura; Seishi Ogawa; Akihiro Tomita; Hitoshi Kiyoi
Journal:  Blood       Date:  2021-03-18       Impact factor: 22.113

4.  Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy.

Authors:  Jing Wang; Muhamad Alhaj Moustafa; Justin J Kuhlman; Karan Seegobin; Liuyan Jiang; Vivek Gupta; Han W Tun
Journal:  Blood Lymphat Cancer       Date:  2022-05-25

5.  An unexpected finding of hepatic lymphoma after emergent cholecystectomy.

Authors:  Shawn T Steen; Evan D Slater; Casey E Barbaro; Emma R Huebner
Journal:  J Surg Case Rep       Date:  2017-03-07

6.  Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.

Authors:  Tomohiro Aoki; Kazuyuki Shimada; Akihiko Sakamoto; Keiki Sugimoto; Takanobu Morishita; Yuki Kojima; Satoko Shimada; Seiichi Kato; Chisako Iriyama; Shunsuke Kuno; Yasuhiko Harada; Akihiro Tomita; Fumihiko Hayakawa; Hitoshi Kiyoi
Journal:  Oncotarget       Date:  2017-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.